Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

4.35

Margin Of Safety %

24

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.09

EPS Last/This Y

1.43

EPS This/Next Y

0.27

Price

30.75

Target Price

40.6

Analyst Recom

1.56

Performance Q

8.97

Relative Volume

0.92

Beta

0.46

Ticker: RPRX




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19RPRX24.250.260.0719013
2024-12-20RPRX24.940.170.0617921
2024-12-23RPRX25.250.110.1414113
2024-12-24RPRX25.380.110.0514189
2024-12-26RPRX25.390.110.0214265
2024-12-27RPRX25.550.110.0114386
2024-12-30RPRX25.330.100.0514475
2024-12-31RPRX25.50.100.2314498
2025-01-02RPRX25.770.100.7314497
2025-01-03RPRX25.840.110.0114546
2025-01-06RPRX25.810.110.4714613
2025-01-07RPRX26.050.110.0014634
2025-01-08RPRX26.390.114.1914826
2025-01-09RPRX26.20.114.1914826
2025-01-10RPRX29.50.150.0215456
2025-01-13RPRX29.990.180.1113493
2025-01-14RPRX30.10.190.0013708
2025-01-15RPRX30.740.150.0216445
2025-01-16RPRX30.980.160.0115946
2025-01-17RPRX30.820.150.0116252
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19RPRX24.25-37.1134.33.97
2024-12-20RPRX24.93-37.1182.53.97
2024-12-23RPRX25.25-37.1163.13.97
2024-12-24RPRX25.23-37.1145.33.97
2024-12-26RPRX25.40-37.1155.53.97
2024-12-27RPRX25.55-37.1154.43.97
2024-12-30RPRX25.32-37.1134.63.97
2024-12-31RPRX25.50-37.1156.03.97
2025-01-02RPRX25.78-37.1160.83.97
2025-01-03RPRX25.84-37.1149.03.97
2025-01-06RPRX25.75-37.1141.63.97
2025-01-07RPRX26.05-37.1162.33.97
2025-01-08RPRX26.20-37.1154.83.97
2025-01-09RPRX26.20-37.1146.33.97
2025-01-10RPRX29.50-37.1319.73.97
2025-01-13RPRX29.99-37.1170.63.97
2025-01-14RPRX30.02-37.1148.03.97
2025-01-15RPRX30.74-37.1180.43.97
2025-01-16RPRX30.97-37.1157.13.97
2025-01-17RPRX30.75-37.3137.03.97
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19RPRX0.00-1.094.13
2024-12-20RPRX0.00-1.094.13
2024-12-23RPRX0.00-1.114.13
2024-12-24RPRX0.00-1.114.13
2024-12-26RPRX0.00-1.114.11
2024-12-27RPRX0.00-1.114.11
2024-12-30RPRX0.00-1.144.11
2024-12-31RPRX0.00-1.144.11
2025-01-02RPRX0.00-1.144.11
2025-01-03RPRX0.00-1.144.11
2025-01-06RPRX0.00-1.154.11
2025-01-07RPRX0.00-1.154.11
2025-01-08RPRX0.00-1.154.11
2025-01-09RPRX0.00-1.154.11
2025-01-10RPRX0.00-1.154.11
2025-01-13RPRX0.00-1.404.35
2025-01-14RPRX0.00-1.404.35
2025-01-15RPRX0.00-1.404.35
2025-01-16RPRX0.00-1.404.35
2025-01-17RPRX0.00-1.404.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

1.01

Avg. EPS Est. Current Quarter

0.96

Avg. EPS Est. Next Quarter

1.09

Insider Transactions

Institutional Transactions

-1.4

Beta

0.46

Average Sales Estimate Current Quarter

622

Average Sales Estimate Next Quarter

Fair Value

38.02

Quality Score

77

Growth Score

75

Sentiment Score

79

Actual DrawDown %

45.6

Max Drawdown 5-Year %

Target Price

40.6

P/E

12.03

Forward P/E

6.88

PEG

1.72

P/S

8

P/B

2

P/Free Cash Flow

6.42

EPS

2.56

Average EPS Est. Cur. Y​

3.97

EPS Next Y. (Est.)

4.24

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

50.52

Relative Volume

0.92

Return on Equity vs Sector %

3.3

Return on Equity vs Industry %

15.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.1

EBIT Estimation

137
Royalty Pharma plc
Sector: Healthcare
Industry: Biotechnology
Employees:
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
stock quote shares RPRX – Royalty Pharma plc Stock Price stock today
news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025
marketwatch RPRX – Royalty Pharma plc yahoo finance google finance
stock history RPRX – Royalty Pharma plc invest stock market
stock prices RPRX premarket after hours
ticker RPRX fair value insiders trading